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Background: Children have reported that one reason for participating in research is to help their doctor. This is
potentially harmful if associated with coercive consent but might be beneficial for recruitment. We aimed to
explore children’s perceptions of the child-doctor relationship in research.
Methods: This is a multicenter qualitative study with semi structured interviews performed between 2010 and 2011
(United Kingdom) and 2017–2019 (the Netherlands). Interviews took place nationwide at children’s homes. We
performed a secondary analysis of the two datasets, combining an amplified analysis aimed to enlarge our dataset, and
a supplementary analysis, which is a more in-depth investigation of emergent themes that were not fully addressed in
the original studies. All participants had been involved in decisions about research participation, either as healthy
volunteers, or as patients. Recruitment was aimed for a purposive maximum variation sample, and continued until data
saturation occurred. We have studied how children perceived the child-doctor relationship in research. Interviews were
audiotaped or videotaped, transcribed verbatim, and thematically analyzed using Atlas.ti software.
Results: In total, 52 children were recruited aged 9 to 18, 29 in the United Kingdom and 23 in the Netherlands.
Children’s decision-making depended strongly on support by research professionals, both in giving consent and
during participation. Often, their treating physician was involved in the research process. Familiarity and trust were
important and related to the extent to which children thought doctors understood their situation, were medically
competent, showed support and care, and gave priority to the individual child’s safety. A trusting relationship led to a
feeling of mutuality and enhanced children’s confidence. This resulted in improving their experiences throughout the
entire research process. None of the participants reported that they felt compelled to participate in the research.
Conclusions: The child-doctor relationship in pediatric research should be characterized by familiarity and trust. This
does not compromise children’s voluntary decision but enhances children’s confidence and might result in a feeling of
mutuality. By addressing the participation of children as an iterative process during which treatment and research go
hand in hand, the recruitment and participation of children in research can be improved.
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Decision-making in pediatric research is difficult because
children are not considered capable of giving informed
consent themselves [1–3]. They do, however, have the
right to participate in all decisions that concern them
[4]. Therefore, assent is required as a way of affirmative
agreement. Children differ in their ability and willingness
to be involved in decision-making, and this is not solely
age-related. [5–8]. The extent to which parents involve
their child in decision-making depends on several factors
including age, risk involved in the research, and whether
parents see involving their child as a parental responsi-
bility [9–12]. Children often trust their parents to pro-
tect, inform, and involve them in decision-making about
participating in research, and also have confidence in
healthcare professionals to help them decide [13]. This
guidance of parents and doctors is mostly perceived as
supportive, yet some young people have experienced a
feeling of pressure from parents, doctors, or both, to
take part in research [14–16].
In a previous study, we found that young people from
the United Kingdom (UK) participated in clinical trials for
a wide range of reasons relating to personal benefit and
helping others including their doctors. We introduced this
as a ‘network of exchange’ [17]. Helping a doctor as reason
to participate could be harmful if associated with coercive
consent. Relevant guidelines, such as the Declaration of
Helsinki, [2] focus either on the process of obtaining
informed consent by an independent professional, or on
emphasizing the voluntary nature of participation [18].
Nevertheless, for voluntary consent and understanding of
the information, children remain at least partly dependent
on the clinicians’ knowledge and expertise [18].
More focus on the researcher-child interaction in the
decision-making process has been found to be likely to
improve children’s perception of research and to make it
more meaningful [19]. Yet little empirical data is avail-
able on how the relationship between children and
doctors influences children in research [20]. We ques-
tion whether the child’s wish to help the doctor by tak-
ing part in research could positively influence children’s
recruitment and their experience of participation with-
out them feeling obliged to participate. Therefore, we
reanalyzed data from our previous study in the UK [17]
and expanded the dataset with newly obtained data from
the Netherlands to further explore the role of the child-
doctor relationship in pediatric research participation.
This will be used to further develop our theory of the
‘network of exchange’ in pediatric research.
Methods
Study Design, Setting, and Participants
This is a multicenter study combining two qualitative
datasets on young people’s experiences in research fromthe United Kingdom (UK) and the Netherlands. The UK
data were used in a previous analysis [17]. The research
teams consisted of two social science researchers (Louise
Locock and Lesley Powell) from the Health Experiences
Research Group (HERG) at the University of Oxford, and a
pediatrician (Eduard Verhagen), ethicist (Els Maeckelberghe),
and MD (Malou Luchtenberg) all based at University of
Groningen, Beatrix Children’s Hospital, University Medical
Center Groningen (UMCG), the Netherlands.
The UK study was approved by the Berkshire Research
Ethics Committee (REC) (09/H0505/66). The UMCG’s
Medical REC concluded that the Dutch study does not
fall within the scope of the Medical Research Involving
Human Subjects Act (M16.192386 2016, May 10th ),
based on national criteria [21].
Participants were approached through national networks,
social media advertising, word of mouth, and healthcare
professionals such as pediatricians. Both studies, from
which the datasets are derived, aimed for a purposive max-
imum variation sample (designed to reflect the broadest
possible range of characteristics and experiences) [22]. in
recruitment based on age (UK dataset: 10–25, Dutch data-
set: 9–18 years), sex, disease or health condition, types of
research they were invited to, and whether or not they had
decided to participate in a study. These types of research
ranged from randomized controlled trials (studying new
drugs, other interventions, or ways of providing patient
information), to birth cohort studies. Children could par-
ticipate if they were able to express themselves in English
(UK study) or Dutch (Dutch study). They received infor-
mation leaflets for them and their parents separately.
Children from an advisory board had been involved in de-
veloping the information. In both studies, oral and written
informed consent was obtained from a parent and assent
from the child. Young people over the age of 16 signed
consent themselves.
Data collection and analysis
We have taken a constructivist grounded theory ap-
proach. In this approach, introduced by Kathy Charmaz,
reality is viewed to be interpretative and relative to social
situations and interactions of people involved, including
participants and researchers [23–25]. A grounded theory
begins with a particular finding and works towards gen-
erating a theory. It is characterized by an iterative
process of data collection and analysis to elucidate a
process [26]. Our starting point was the finding in our
previous study that young people expressed a wish to
help or give back to their doctors by participating in
medical research [17]. We went back to the UK data and
performed a supplementary analysis, which is a more in-
depth investigation of emergent themes that were not
fully addressed in the original study [27]. Because we
wanted to explore children’s experiences from a broader
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bined the two datasets in an amplified analysis aimed to
enlarge our dataset, rather than comparing the two [27].
Both datasets comprised semi structured in depth
interviews (30 to 100 min) with children about their
experiences with medical research at their home.
Primary data from the UK study were collected by
researchers from HERG from January 2010 to December
2011, and were used to contribute to the Health Talk
website [28]. This is a website about real-life experiences
of health and illness. The Dutch data were collected
consistent with the UK methodology from May 2017 to
January 2019. The interviewers, introduced to partici-
pants as researchers (LP: PhD, female, UK children, and
ML: MD, PhD candidate, female, Dutch data), were
trained at HERG. The interviewers had no prior relation-
ship with the participants, and clarified to them not having
influence on their medical care. A topic guide, based on the
primary UK study [17] was created to structure the Dutch
interviews. The main topics included reasons for (not)
participating, information and decision-making including
feeling obliged to take part to help their doctor, experiences
during participation, involvement of doctors and parents,
and children’s advice on how to improve their experience.
The topic guide is presented in Table 1. Field notes were
taken after the interview took place, and the topic guideTable 1 Topic guide
Main topics Subtopics for further prompting
Introduction to research Importance of research
By who approached
Circumstances
Healthy volunteer vs. patient
participant
Information Oral and written information
Other sources of information






Decision-making Who gave consent
Influence of others such as parents
and doctor
Voluntary choice














Most important things discussedwas updated during data collection, which aimed at data
saturation. All interviews were audiotaped or videotaped,
and transcribed verbatim. Names of persons and locations
were removed from the transcript. Transcripts were
checked by the interviewer, and returned to the participant
to check and remove any sections they wished not to be
used. In the primary UK study, a few sections were
removed for the website. These were not included in this
analysis. The Dutch participants did not remove any
sections. We only used the transcripts of both datasets for
our analysis.
Our analysis started while the Dutch data were being
collected. ML and EM took on the initial coding of the
interviews to find how children described the relation-
ship with their doctor in different stages of the research
process including how their doctor’s actions may or may
not result in a wish to “give something back” to their
doctor. After the initial coding, ML performed a more
focused coding in which emergent themes about the
child-doctor relationship including the roles children
assigned themselves and doctors were analyzed. This
was an iterative process in which themes were constantly
compared to each other to find associations between
and within the themes. This was supervised by EM (UK
and Dutch data) and LL (UK data). The findings were
discussed regularly with the entire research team
through face-to-face meetings and by video-discussions.
Differences were resolved through consensus. Atlas.ti
software was used to help organize and analyze antici-
pated and emergent themes across the two datasets.
Results
Sample
In total, 52 participants aged 9–18 years were included in
this study; 29 from the UK, and 23 from the Netherlands.
Three participants from the original UK dataset had been
excluded because they were over 18 to prevent adult inter-
pretation of childhood experiences. For the primary UK
study, sometimes a parent was present at the interview
and sat next to his or her child. Sections where parents
had expressed their views were not included in the ana-
lysis. In the Dutch study, only in one case a mother sat
next to her child during the interview. She answered some
questions when her child had difficulties to express him-
self due to his medical condition. These answers were only
included when the mother clarified what her child tried to
say. Participant characteristics are shown in Table 2.
Children’s experiences of their relationship with health
professionals in research
We found that health professionals, mostly doctors, play an
important role in children’s experiences with participation
Table 2 Participant characteristics
Characteristics UK data
Na (%)
Dutch data Na (%) Na (%)b
Sex
Girl 18 (62) 9 (39) 27 (52)
Boy 11 (38) 14 (61) 25 (48)
Age
9,10 years 1 (3) 4 (17) 5 (7)
11, 12 years 8 (28) 6 (26) 14 (27)
13, 14 years 8 (28) 9 (39) 17 (33)
15, 16 years 4 (14) 3 (13) 7 (13)
17, 18 years 8 (28) 1 (4) 9 (17)
Disease
Acute diseases (Acute Lymphoblastic Leukemia, brain tumor,
Hodgkin’s lymphoma)
4 (14) 3 (13) 7 (13)
Common chronic diseases (DM1, Crohn’s disease, asthma,
arthritis, migraines)
13 (45) 7 (30) 20 (38)
Rare chronic diseases (peanut allergy, glycogen storage
disease, hypophospatic rickets, vasculitis, Lupus, Wegener’s
granulomatosis, osteogenesis imperfecta, cystic fibrosis,
Grave’s disease, overlap connective tissue disease, tuberous
sclerosis complex)
7 (24) 8 (35) 15 (29)
Other health conditions/syndromes (congenital heart
condition, Prader-Willi Syndrome, restricted growth)
1 (3) 3 (13) 4 (8)
Healthy 4 (14) 2 (7) 6 (12)
Participants decided to:
Participate 27 (93) 19 (83) 46 (90)
Not participate 1 (3) 3 (13) 4 (8)
Withdraw 1 (3) 1 (4) 2 (4)
a Number of participants; UK data N= 29, NL data N = 23, total N = 52
b Rounded to nearest whole number
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what the exact roles were. In some cases, the treating phys-
ician helped only with recruitment, while in other cases,
this physician appeared to be one of the doctors from the
research team.
Familiarity and trust were reported to be important
and related to the extent to which children thought
doctors understood their situation, were medically com-
petent, showed support and care, and gave priority to
the individual child’s safety. The relationship sometimes
ensued in a feeling of mutuality, meaning that they
wanted to help others or give something back to the
doctor specifically, and it enhanced children’s confi-
dence, which resulted in improvement of their experi-
ences. Children wanted to be acknowledged and they
wanted to show that they saw themselves not just as
patients or participants but also as persons who recipro-
cate. This provides a deeper understanding of the
exchange between children and health professionals as
part of the ‘network of exchange’ which we introducedin our previous study [17]. Table 3 provides the codes
and themes which were extracted and which informed
our theory.
Trust, familiarity, confidence and mutuality ran
through all different stages in the research process,
which we will present in turn: when children were in-
vited and considered research participation; when they
made the decision whether to participate, and during
their participation including looking ahead to future
participation.
Invitation and consideration of research
The way children referred to the person who first
approached them revealed that familiarity and trust
were important. When invited to participate in
research by their own treating physician, children de-
scribed feeling more open to considering the research
because they felt at ease and confident because this
doctor was acquainted with their situation.
Table 3 The child-doctor relationship in research as a network of exchange
Theory Network of exchange
Themes Familiarity Trust Mutuality Confidence
Roles Professional Child
Treating physician Researcher Research team Person Patient Participant
Codes Having competence
Understanding situation
Giving support and care
Putting child’s individual safety first






Wanting to help others (voluntarily)
Being (more) open to future research
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weeks before diagnosis. So yes, I did see [the doctor] as
a confidant, someone who knows what he was talking
about. So, when he asked me that question, it didn’t
feel strange at all to me. I actually experienced it as
pleasant. If two strangers stood at my bed side, asking
if I wanted to participate in research, that would
maybe, um, be a little bit more confusing. So, I
thought…. Um, it was kind of nice that he asked me.”
(Child01; age 17, took part in RCT for Crohn’s
disease treatment).
One girl said it helped that her doctor introduced the
researcher who invited her to take part. Others reported
that a familiar face of someone they had only noticed by
accident in the hospital helped. They worried more
when invited by a stranger.
“Just talking to people I didn’t really know. And it
was just a bit weird that they knew a lot about me,
and I didn’t know anything about them. Because I
didn’t even know any of their names. …Yes, it, like it,
the second time I went they introduced themselves,
but not the first time. So, I was a bit shy.” (Child02;
age 12, took part in RCT for a new drug for
arthritis).
Having compassionate people around them was sup-
portive. One participant with a chronic disease explained
how she believed her longstanding relationship resulted
in some sort of mutuality. She thought the relationship
helped the health care professionals to feel confident
about inviting her to take part, and it helped her in feel-
ing confident to ask questions about the research.
“I think they feel that they were more able to come
up to me because they can, I’m more approachable.
Because they know me very well and I’ve been there
a long time and they know that I’ll help anything
that they need to do. But I think they, I think theystill would ask anyone, even if they were just new di-
abetics. I don’t think that really had much of an im-
pact. But they were just able to talk to me more
about it. …I felt more comfortable saying like, I
could say what I think in front of them and they
won’t take anything the wrong way. Or if I need to
ask questions, no matter how stupid it is, they’ll just
answer it.” (Child03; age 17, took part in RCT
comparing different ways of providing information
to Type 1 diabetes patients).
Familiarity was important when children considered
participation. They often discussed their wish to partici-
pate or not with their treating physician, even if he or
she did not have a formal role as researcher. Children
felt reassured knowing that the doctor would always put
their individual safety first. They emphasized that for
example in randomization, their doctor could always
take them off the study if their safety was at risk.
“Not really [worried], because like I’m sure they could
find out if they really needed to, if it was an emergency.
…Yes [it helped knowing them], because like they’re
really nice and friendly and they tell you what they
think and what they think is best, and like they only do
what they think is best.” (Child04; age 13, took part
in RCT to test a new drug for arthritis).
Decision about taking part
Trust was expressed by some participants as a precondi-
tion for taking part.
"…I think if they didn’t, I don’t think, I think if I
didn’t trust them or if I felt that I couldn’t trust
them with whatever I said, I don’t think I would
have taken part. Because to me, I, trust is a main
thing. And if I don’t trust someone then it’s just like,
“Well, I can’t really say nothing to you.” (Child05;
age 15, took part in RCT comparing two different
types of insulin for Type 1 diabetes patients).
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research team were reportedly important to children
considering research participation, this alone was not
necessarily a reason for them to decide to take part. Other
considerations, such as the type of intervention and burden
involved also influenced their decision. Some participants
reported some influence of their doctor in their decision,
but that they had never felt compelled.
“No. No no no, not at all. [laughs] No, it is just a
question to which you can say yes or no and eh, if I
say no then it’s not like there’s going to be a letter
saying like ‘please’, you know? No, not at all. No, but
I also think that if you’d feel obliged then they
haven’t told you well, because it shouldn’t be the
way you treat your test persons I believe.” (Child06;
age 16, took part in several trials including different
diagnostic tests for patients with congenital heart
disease).
One participant stated that her doctor trusting her and
showing confidence in her decision helped her to make
up her mind.
“Where I did really well was that my consultant
realized that I was old enough and mature enough
to make my own decisions and he didn’t talk to my
parents, he talked to me and that is what made me
have the confidence to make that decision myself
because he knew that I was mature enough to
understand it, he spoke to me like I was an adult
and that made all the difference.” (Child07; age 12,
declined to take part in an RCT about a new drug
for leukemia patients).
Many participants described how they wanted to help
their doctor by participating. They identified themselves
as reciprocal persons who wanted to give something to
their doctor in return. This motivation was often com-
bined with the desire to help future sick children, or to
help the hospital or research in general.During and at the end of participation
Support and care from the research team and having
knowledge of the situation were decisive for children in
feeling reassured and confident to continue with the
study. Children said that they appreciated getting to
know the researcher in situations where no familiarity
was previously established. This happened especially
with healthy volunteers who were either invited by a
stranger, or via a letter or e-mail. One of the healthy
volunteers emphasized that it was very important that
the people she met during the research interventionwere supportive, able to give her information, and
answer her questions.
“Um, perhaps in a way I would have found it
pleasant to have met the researcher, but I don’t
think it’s necessary to have spoken to that person,
because the other person who helped me [a
research assistant] knew some things about it. So,
I think it’s important that the one that is helping
you knows about it [the research].” (Child08; age
16, took part in clinical trial testing different lung
function tests as healthy volunteer).
Patient participants accentuated that supportive,
knowledgeable, and familiar professionals contributed to
feeling comfortable and safe about staying in the research.
One girl mentioned that for her a lack of trust in the re-
search team would be a reason to withdraw from a study.
“If I wanted to stop, my reasons would have to be I
didn’t trust the people who I, like I was with, I didn’t
like how I was being told to do things or being
treated, and, and I didn’t feel comfortable doing the
trial. All those things, I would not do the trial.
Because I feel like I need to trust them, I need to
know what I’m doing, and if I didn’t feel comfortable
doing it, I just couldn’t do it, I just wouldn’t be able
to do it.” (Child05; age 15, took part in RCT
comparing two different types of insulin for Type 1
diabetes patients).
For many children it was unclear whether the research
they took part in had already ended or not. Some chil-
dren wanted to be updated about the results. Especially
when their reason for participating was to help others,
they were curious about the value of their contribution.
“Because yes, you are… you are in a process and
you’re working towards something, kind of. So, you
do hope to, eh, get to see or hear some results about
it yes. Because, as I said, you are doing it for science
and it would be nice if you kind of see like ‘this is
what it brought because of you or the group you were
participating in’.” (Child01; age 17, took part in
RCT for Crohn’s disease treatment).
Children expressed that their research experience had
improved their understanding of their disease and it
helped them to regain trust in their own bodies. It also
made them feel more confident in managing their health
condition.
“Now, we can… by now we also understand it a
little. We have injected it more often now, so we
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things [materials]. And how… which protocol we
have. Yes, it’s going pretty well. Yes. Good.” (Child09)
“Yes, she [our mother] has followed a training in
that. Yes, it was part of it. That she knows how to do
it, so in principal she could easily do it [the injection].”
(Child10; sibling of Child09, age 14, took part in a
drug trial for hypophosphatemic rickets) “…But we
thought, we could do it ourselves as well. …Yes, I am
… I like that idea. Yes. As I just said, it gives me
some sort of feeling like yes… it’s some kind of
confidence you know?” (Child09; age 13, took part in
a drug trial for hypophosphatemic rickets).
Some participants said they felt more open to future
research opportunities because of their positive experi-
ences, especially when it concerned research that was
introduced by their own treating physician.
Discussion
This study explored how children experienced the child-
doctor relationship in research. For patients, we found
that familiarity and trust in their treating physician was
important for considering participation, for consenting to
participate, for remaining in a study, and for considering
future participation. Interestingly, the trusting relationship
between patients and their treating physician sometimes
led to a feeling of mutuality, and this enhanced children’s
confidence. Healthy volunteers, who did not have a prior
relationship with a doctor or researcher, depended more
on parental support when introduced to research. Healthy
volunteers also expressed that becoming familiar with the
researcher was important to feeling reassured about con-
tinuing the research. None of the participants reported
that they felt obliged to take part in research. We will
elaborate on why trust in professionals matters, consider
the intertwinement of research and care, and stress the
importance of treating children’s research participation as
an iterative process to improve their engagement in
research.
Trust placed in the treating physician
Our findings confirm results of Tromp and Van de
Vathorst that parents and adolescents report personal
trust as being an important factor in the decision to par-
ticipate in clinical trials [29]. According to O’Neill, trust
cannot be replaced by other values such as transparency,
autonomy, or accountability [30]. She states: “where we
aim not to influence others, but to place and refuse trust
intelligently, we must link trust to trustworthiness, and
must focus on evidence of honesty, competence and reli-
ability.” [31]. Children in our study said they trusted
their doctor who knew about their situation and had
shown to be able to make truthful claims based on theirspecific situation (honesty). In addition, children experi-
enced that their doctors had the ability to do what they
said (competence), and that the doctors had provided
support and care. Therefore, the doctors had shown
commitment to the children (reliability). The value of
trustworthiness of the doctor-researcher could explain
why healthy volunteer participants, who lack such a
prior relationship, were more cautious during their first
contact with the research team and hospital.Intertwinement of research and care
Trust and familiarity seemed to be particularly import-
ant for supporting children whose treatment intersected
with the research they were invited for, especially in
situations where the consequences were not always
foreseeable, such as when children were overwhelmed
because they had recently been diagnosed, or when chil-
dren were to be randomized to receive a specific drug.
The importance of trust and familiarity in coping with
these uncertainties in research seems to be similar to
coping with disease in the (regular) health care setting.
Parents of children with a rare disease for example,
expressed the importance of mutual trust in decisions
about treatment, [32]. and others recognized the import-
ance of tailored care and support for their children with
trisomy 13 and 18 [33]. Trust and respect in relation-
ships with healthcare providers were found to be essen-
tial facilitators for shared decision-making in pediatrics
[34]. Our participants did not always report a trusting
patient-doctor relationship to be a precondition for tak-
ing part, but they did mention feeling less worried and
more open towards research participation. This confirms
findings from the study of Dekking et al. in which par-
ents said they valued the involvement of their child’s
physician in the informed consent process [35]. When
the informed consent procedure is done by someone
that is “completely independent of this relationship”, as
required in the Declaration of Helsinki (article 27), [2]
this might have the consequence that children will not
be open to considering the research, even though they
may otherwise be willing to participate.
In some areas, such as pediatric oncology, a strict
division between the physician and researcher role is not
always possible, and dividing the two roles can cause prob-
lems in communication between them [36]. This blended
role of the treating physician and researcher requires
responsibility and a constant awareness of the professional
of potential conflicts. Given the similarities in patient-
doctor relationships in health care and research, it could
be questioned whether it is realistic to hold on to a strict
separation of the doctor’s role as treating physician and as
researcher, or that it might be better for the two roles to
go hand-in-hand, as in pediatric oncology.
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Support and interaction with the research team during
participation seemed to help our participants in coping
with uncertainties and decision-making. Decision-making
was not restricted to the single moment of giving
informed consent but was also directed at decisions about
retention in a study, or decisions about future research.
An alternative, more personalized approach towards in-
formed consent, leaving more room for trustworthiness,
honesty, and openness in the patient-doctor relationship,
has been suggested for clinical genetic testing [37]. Budin-
Ljosne et al. pointed out that more focus on the relational
and societal aspects of research and ongoing communica-
tion between the participant and researchers through
dynamic consent, could improve recruitment in research
[38]. We recommend seeing children’s participation in
pediatric research as an iterative process, whereby
decision-making and interaction between the research
team and the participant takes place during the entire
process, and is not only related to consent. This approach
seems to connect well to the positive experiences the
young people mentioned at the end of their participation,
which could encourage trial participation in the future.
Recently, Sisk and Baker published a model for trust and
relationship maintenance in pediatric care [39]. They
hypothesize that doctors should demonstrate caring, fidel-
ity, and honesty, in addition to competence, to maintain
and build trust over time. Our findings illustrate that this
iterative model might also work for research relationships.
Strengths, limitations, and future research
By combining the UK and Dutch datasets we obtained
extensive data about children’s experiences with partici-
pation in different kinds of medical research. The
children included both patient participants and healthy
volunteers, and children who declined or withdrew from
research. Having obtained more data from children who
did participate in research could have had a positive
influence on our view of the trusting relationship be-
tween children and professionals. Nevertheless, the data
obtained from children who decided not to participate
also showed that trust was important. Those children
expressed other reasons to decide not to take part in
research, and not a lack of trust.
In some of the interviews in the UK, a parent sat next
to the child when the interview was taken. Unfortu-
nately, it was not formally recorded how often this was
the case, and we only had access to the interview tran-
scripts for this secondary analysis. Although the views
expressed by parents were not taken into account and
children themselves seemed very open about their expe-
riences, children may have been influenced in what they
said as a result of the presence of a parent. This is a
potential limitation of our study. Another limitationmight be that some sections in the primary UK study
were permanently removed at the request of participants
before being used on the website, and could therefore
not be taken into account for this secondary analysis.
The removed sections, however, occurred in only five
transcripts, and contained a few seconds of data to a
maximum of one minute. Although the sections around
those parts of the data mainly concerned other topics,
we cannot fully be sure that it has not affected the valid-
ity of our results.
The influence of familiarity and trust on children’s
decision-making might be affected by the child’s age and
the type of research the child in invited to. In our popu-
lation, age did not seem to be influential, but the type of
the study and whether it affected children’s disease man-
agement did seem to matter. Children who took part in,
for example, a randomized controlled trial that involved
a change in their treatment put more focus on the import-
ance of trust as a precondition for taking part, and also
during the research itself, whether healthy volunteers who
took part in a trial that did not directly affect their health
felt that becoming familiar with the researcher was im-
portant but not a prerequisite. Future research should
focus on the influence of those aspects. We believe this
needs future studies with a more quantitative or mixed
methods approach.
Conclusions
Children’s experiences suggest that in pediatric research
the child-doctor relationship should be characterized by
familiarity and trust. When research intersects with chil-
dren’s treatment, the combined physician-researcher role
did not seem to be associated with involuntary participa-
tion, but rather with desire of mutuality, and it enhanced
children’s confidence. This shows the importance of
building a trustful relationship with children in research
that goes beyond procedural requirements. Addressing
children’s participation as an iterative process in which
treatment and research go hand-in-hand could poten-
tially improve recruitment and engagement of children
in medical research.
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